TGF-β signaling promotes eosinophil activation in inflammatory responses

Area of Science:

• Immunology
• Cell Biology
• Inflammation Research

Background:

• Eosinophils are key players in inflammation, but mechanisms of their activation are not fully understood.
• Their pro-inflammatory roles are increasingly recognized, necessitating deeper investigation into regulatory pathways.
• Understanding eosinophil activation is critical for developing targeted therapies for inflammatory diseases.

Purpose of the Study:

• To investigate the mechanisms of local eosinophil activation within inflammatory environments.
• To identify key signaling pathways regulating eosinophil activation and function.
• To explore the role of TGF-β in eosinophil activation in models of asthma and colitis.

Main Methods:

• Transcriptional sequencing to identify potential regulators of eosinophil activation.
• Genetic deletion of TGF-β receptors on eosinophils.
• Utilizing mouse models of house dust mite (HDM)-induced asthma and dextran sulfate sodium (DSS)-induced colitis.

Main Results:

• Transcriptional sequencing identified TGF-β as a regulator of eosinophil activation and peroxidase secretion.
• Genetic deletion of TGF-β receptors inhibited eosinophil peroxidase synthesis, confirming TGF-β's role.
• TGF-β-driven eosinophil activation was essential in both asthma and colitis models.
• TGF-β signaling did not affect asthmatic inflammation but protected against experimental colitis.

Conclusions:

• TGF-β signaling is a critical regulator of eosinophil activation, influencing peroxidase secretion.
• Eosinophil activation via TGF-β plays a context-dependent role in inflammatory diseases like asthma and colitis.
• These findings provide insights into eosinophil pathophysiology and potential therapeutic strategies for inflammatory conditions.